COL5A2 was involved in osteosarcoma cell proliferation and invasion, provided new insights into cytostatic drug resistance of ovarian cancer, and represented early potential diagnostic biomarkers and therapeutic targets for bladder cancer [42–44]. The gene discussed is COL5A2; the disease is urinary bladder carcinoma.